Circassia Pharmaceuticals (CIR)

Sector: Pharma and Biotech     Index: FTSE Small Cap
-0.29%
-0.25p
85.50p
17:18 22/06/17
85.50p
17:18 22/06/17
DAILY VARIATION
-0.29%
-0.25p
VOLUME
127,239
No results
REAL TIME BATS
85.00p
17:36 22/06/17
-0.73%
-0.63p
DATA
52 Week High
n/a
52 Week Low
n/a
Shares Issued
332.24m
Market Cap
£284.07m
RiskGrade
n/a
Beta
n/a
MENU

Circassia Pharmaceuticals Overview

Circassia is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Intraday Chart

No results

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -655.8% -180.3%
ROCE 0.0%
Latest F'cast
P/E -1.8 0.0
PEG 0.0 -999,999.0
Pr/Revenue 12.2 5.9
Pr/Book 1.0
Latest F'cast
Revenue 113.9% 13.6%
PBT 0.0% n/a
EPS 0.0% 3.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 n/a -44.00 -21.00p -13.3 0.0 n/a n/a 0.0%
2015-12-31 10.80 -62.80 -20.00p -16.0 0.0 n/a n/a 0.0%
2016-12-31 23.10 -144.90 -48.00p -2.0 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 48.86 -88.10 -23.11p 0.0 n/a 0% 0.00p 0.0%
2018-12-31 71.12 -40.24 -9.73p 0.0 n/a 0% 0.00p 0.0%

Regulatory News

slide to see more

Newspaper Links

No results found